Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Starboard Takes Stake in Pfizer
Pfizer CEO Bourla To Meet Activist Investor Starboard, Report Says
KEY TAKEAWAYS Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion stake in the struggling drugmaker.Bourla and at least one other director will hold discussions with Starboard next week,
Bloomberg Businessweek: Starboard Takes Stake in Pfizer
Carol Massar and Tim Stenovec bring together the latest news from the world of business and finance and the interesting stories.
As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?
While Pfizer has made a number of acquisitions, its biggest bet is on Seagen. Pfizer wants this to be a transformative acquisition, and it projects Seagen to contribute $10 billion in sales by 2030. It said following the deal, it now has eight or more potential blockbuster drugs in its pipeline.
2d
on MSN
These Stocks Moved the Most Today: Pfizer, Super Micro, Generac, Apple, Amazon, Arcadium Lithium, Tesla, Netflix, and More
Activist investor Starboard has taken a $1 billion stake in Pfizer, according to a report, Super Micro stock surges, and ...
1d
Pfizer: A Strong Product Pipeline Could Lead To Significant Upside
Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
2d
on MSN
Why Pfizer Stock Popped on Monday
Pfizer ( PFE 3.18%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...
1d
Pfizer CEO plans to meet activist investor Starboard, FT reports
Pfizer CEO Albert Bourla plans to meet key executives of activist hedge fund Starboard Value next week, the Financial Times ...
6d
Is Pfizer a Buy Right Now or a Value Trap?
On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...
2d
Pfizer’s Stock Buy Rating: Undervalued with Growth Potential and Strategic Management Actions
Evan Seigerman, an analyst from BMO Capital, maintained the Buy rating on Pfizer (PFE – Research Report). The associated price target ...
2d
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Monday. Shares of Pfizer Inc PFE rose during ...
1d
Stock Market Today: Dow edges up, Nasdaq rises 1% as stocks rebound from Monday's selloff
The Roundhill Magnificent Seven ETF — which holds Big Tech stocks including Nvidia, Apple Inc., Microsoft Corp, Alphabet Inc.
2d
Pfizer (PFE) Gets a Hold from J.P. Morgan
J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $30.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Starboard Value
Adobe Systems
The Wall Street Journal
Financial Times
Feedback